Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine, AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
DEFA14A

Additional proxy soliciting materials - definitive

 View HTML
0001558370-20-004641.pdf
0001558370-20-004641.rtf
0001558370-20-004641.xls
DEFA14A

Additional proxy soliciting materials - definitive

 View HTML
0001558370-21-004559.pdf
0001558370-21-004559.rtf
0001558370-21-004559.xls
DEFA14A

Additional proxy soliciting materials - definitive

 View HTML
0001558370-22-006383.pdf
0001558370-22-006383.rtf
0001558370-22-006383.xls
DEFA14A

Additional proxy soliciting materials - definitive

 View HTML
0001558370-23-007344.pdf
0001558370-23-007344.rtf
0001558370-23-007344.xls
S-1/A

Amended Registration statement for face-amount certificate companies

 View HTML
0001047469-15-003351.pdf
0001047469-15-003351.rtf
0001047469-15-003351.xls
S-1/A

Amended Registration statement for face-amount certificate companies

 View HTML
0001047469-15-003668.pdf
0001047469-15-003668.rtf
0001047469-15-003668.xls
10-K/A

Amendment to a previously filed 10-K

 View HTML
0001558370-18-006096.pdf
0001558370-18-006096.rtf
0001558370-18-006096.xls
10-Q/A

Amendment to a previously filed 10-Q

 View HTML
0001558370-16-006732.pdf
0001558370-16-006732.rtf
0001558370-16-006732.xls
10-Q/A

Amendment to a previously filed 10-Q

 View HTML
0001558370-18-006098.pdf
0001558370-18-006098.rtf
0001558370-18-006098.xls
4/A

Amendment to a previously filed 4

 View HTML
0001179110-17-009848.pdf
0001179110-17-009848.rtf
0001179110-17-009848.xls